If this message is not displayed correctly, click here.

No 96, February 2017

Join the ERA-EDTA Photo Contest and win a free registration for the Madrid Congress!

Join the ERA-EDTA Photo Contest and submit a photo on the World Kidney Day 2017 theme “Kidney Disease & Obesity. Healthy Lifestyle for Healthy Kidneys” by February 25, 2017.

The submitted photos will be posted on Instagram and the number of “likes” will decide the winners.

Read the rules and click here to participate!

54th ERA-EDTA Congress Satellite CME: Hands-On Renal Nutrition Course for Healthcare Professionals (June 1-2, 2017 Madrid, Spain)

Do you want to become a nephrologist or a dietitian trained comprehensively in nutrition? Now you can. Register for TNT (Total Nutrition Therapy) Renal, the first ever international course in nutrition designed for this purpose. This is a 2-days course, endorsed by ERA-EDTA, which covers the pathophysiology, prevention and treatment of protein energy wasting in kidney disease. The course has been designed and is led by renowned experts from ISRNM. Participants will be provided with a certificate by the ISRNM if they complete a post-test successfully. Click here to download the scientific programme.

Just published online! Read the latest NDT and CKJ articles

Just published online! Read the latest NDT and CKJ articles

CKD Management in Primary Care: it is not all about ACEI/ARB!
A systematic review and meta-analysis of chronic disease management interventions for people with CKD in primary care was performed and has been published in the latest edition of NDT.  The efficacy of chronic disease management (CDM) interventions was assessed by using quality indicators [mainly use of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB)]. Compared with usual care, neither computer-assisted nor education-related CDM interventions increased the likelihood of ACEI/ARB use among patients. The authors concluded that other strategies, or multifaceted interventions, may be required to enhance care for CKD patients.

 Read More →

aHUS: Is it possible to stop therapy?
Atypical haemolytic uraemic syndrome (aHUS) is a rare, life-threatening disorder for which eculizumab is the only approved, though very expensive, treatment. Life-long treatment is indicated however, eculizumab discontinuation has been reported. This analysis, which has been published in ckj, has focused on available data for the medical evaluation of eculizumab discontinuation and TMA risk. In conclusion, it is not yet clear whether patients with or without identified genetic mutations are at higher risk of new TMA manifestations when eculizumab is discontinued until tools are available to provide more robust risk stratification and adequately monitor complement activation and disease activity. Therefore, the option to discontinue eculizumab will not be an evidence-based decision.

 Read More →

ERA-EDTA Flash is the official ERA-EDTA eNewsletter

Editor-in-Chief: Mustafa Arici
Editorial Secretariat: Valentina Cocchi
Newsletter Design: Ilaria Martini

ERA-EDTA Headquarters
Via XXIV Maggio, 38
43123 Parma - Italy

The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003. If at any time you wish to change personal information that is incorrect or wish to have your personal data deleted, please REPLY this email and specify ‘REMOVE ME FROM YOUR DATABASE’. ERA-EDTA will meet such requests at the earliest possible opportunity by deleting or amending your personal information.